Common Infusions for Neonatal Use

Similar documents
Cardiac Catheter Labs Intravenous Drug Therapy Guide

Neonatal Guidelines. Chapter 15: Pharmacy related Version: Date Revised: 24 th January 2017

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use

Medication Calculation Practice Problems

NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES

Protocol for Ferric Carboxymaltose (Ferinject ) Injection Use in Paediatric Services

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick Neonatal Pharmacist

PARENTERAL NUTRITION

** Medication exercises ** NICU Phase II

Math for Meds. College of Southern Nevada. Practice Problems. Nursing 211

ADENOSINE. ADRENALINE (Epinephrine)

Contributes to CQC Outcome number: 9&12 Consulted With Post/Committee/Group Date. Pharmacist. Alison Felton Head of Pharmacy/Deputy Chief.

CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY

PATIENT SAFETY ALERT

concentrate intravenous solution and other strong potassium solutions

Southern Trust Home IV Service. Guidelines for the administration of IV antibiotics

Resuscitation Fluids

TOTAL PARENTERAL NUTRITION

LRI Children s Hospital

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain

Paediatric Anticoagulant Guidelines. Bhavee Patel, Gareth Thomas

Step-by-step instructions for intravenous (iv) infusions for patients with:

RECONSTITUTION, DOSING AND ADMINISTRATION

Section 8.4 Special Dilutions

** Medication exercises ** NICU Phase II

DOCUMENT CONTROL PAGE

DRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy)

Good practice for drug calculations

Paediatric Prescribing Pocket Guide September 2014 (Version 1)

IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM

Guidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings

A Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children

I write in response to your request for information in relation to pharmacy drug guidelines within NHS Lothian.

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults

PHARMACOLOGY AND PHARMACOKINETICS

Critical Care Standard Infusion Concentrations

APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline

LET - Maths, Stats & Numeracy

Extravasation injuries. Amendments Date Page(s) Comments Approved by 03/16 ALL Completely updated guideline

INTRAVENOUS THERAPY INSTRUCTIONAL PACKAGE

PRESCRIBING INFORMATION. Dextrose Injection USP. (Concentrated Dextrose for Intravenous Administration) 50% (500 mg/ml) Fluid and Nutrient Replenisher

Injection Dosage Calculations

INTRAVENOUS HYDRALAZINE POLICY

Within the proportion the two outside numbers are referred to as the extremes. The two inside numbers are referred to as the means.

IV drug preparation guidelines. Prepared by pharmacist Eman Elayeh

Care homes - Homely remedies

ASEPTIC DISPENSING TECHNIQUES/DRUG- NUTRIENT INTERACTIONS

Medication Safety Mandatory Training

Nonparenteral medications

Ratios and Proportions. Calculations for Pharmacy Technicians 9/21/2017. Presented by: Antonia Kraljevic PGY2 Pharmacy Practice Resident

Artesunate 60 mg for injection WHOPAR part 3 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 PATIENT INFORMATION LEAFLET

Artesunate 120mg powder for injection (Guilin Pharmaceutical Co., Ltd), MA90 LABELLING. Page 1 of 6

REDUCING THE RISK OF MEDICATION ERRORS WITH INTRAVENOUS MAGNESIUM SULFATE This bulletin has been developed by Wessex Academic Health Science Network

Artesunate 60 mg for injection WHOPAR part 3 November 2015 (Guilin Pharmaceutical Co., Ltd.), MA051 PATIENT INFORMATION LEAFLET

SOP for the Prescribing and Administration of Milrinone on The Children s Heart Centre

Joint Trust Guideline for the Management of Methylprednisolone Sodium Succinate Infusion for Child or Young Person A Clinical Guideline

Catalogue. Medication Safety Labels CONTENTS 1. For the Safe Management of Medication Version 2. Anaesthetic Syringe Labels

UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH

Pharmaceutical risk management strategies for parenteral nutrition. J. Eastwood (UK)

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate

Sources and magnitude of error in preparing morphine infusions for nurse/patient controlled analgesia in a UK paediatric hospital

IV Referral Standards for OPAT Services

Developing a pathway of. and care planning for people with diabetes

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Algorithms for Symptom Management. In End of Life Care

Syringe driver in Palliative Care

Artesunate 60 mg for injection WHOPAR part 5 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 LABELLING

Duct Dependant Congenital Heart Disease

CosmoFer. Dose Selection and Calculation Guide for intravenous administration. Low molecular weight iron dextran. Revised TDI tables

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE

LRI Children s Hospital

CLINICAL GUIDELINES ID TAG

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate

Paediatric Formulations The Clinical Perspective

ROSOBAC-1GM / ROSOBAC-FORT

INTRAVENOUS FLUID THERAPY

Davis s Drug Guide Scavenger Hunt 15 th Edition

PHARMACY DOSING AND ORDERING GUIDE

Reducing the risk from medication errors with IV Magnesium Sulfate

Acknowledgements. Reducing the risk from medication errors with IV Magnesium Sulfate

patient group direction

CICU STANDARD INTRAVENOUS INFUSIONS CHART

Specialist Palliative Care Audit and Guidelines Group (SPAGG)

Dextrose 5 normal saline and metronidazole compatible

DRUG GUIDELINE SODIUM NITROPRUSSIDE

Rapid Response Report 2

Drug Shortages with Parenteral Nutrition

Diabetes Labour guideline (GL820)

Paediatric Nephrology Date of submission March 2014

Diabetes Emergency Caesarean section or other unplanned surgery (GL822)

DR J HARTY / DR CM RITCHIE / DR M GIBBONS

UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016

INTRAVENOUS FLUIDS PRINCIPLES

ACETYLCYSTEINE INJECTION

Module 8: Practice Problems

Transcription:

Common Infusions for Neonatal Use Document Title and Reference : Common Infusions for Neonatal Use Main Author (s) Dr N B Soni Ratified by: LSC CEG Date Ratified: May 2016 Review Date: May 2018 Version: V2 Document status: LSC approved document The Network (NWNODN) consists of 3 locality neonatal networks, Cheshire and Merseyside (CM) Lancashire and South Cumbria (LSC) and Greater Manchester (GM). This document has agreed by locality Clinical Effective Groups (CEG) and can be adapted for local use. Please acknowledge source if this document is adapted for local use. LSC Common Infusions for Neonatal Use Page 1

Table of Contents Introduction... 3 Adrenaline... 4 Dobutamine... 6 Dopamine... 8 Insulin... 10 Morphine... 12 Appendix 1... 14 Appendix 2... 15 LSC Common Infusions for Neonatal Use Page 2

Introduction This document sets the standard to improve nutritional intake of PN by minimising the volume of non-nutritive continuous infusions and maximising calorie intake of PN by using standard concentrated formulations and infusion rates. This document should be used in conjunction with the standardised Lancashire & South Cumbria Neonatal Network Parenteral Nutrition Guidelines The standardisation of infusions across network would lead to 1. Similar infusions when babies move between network hospitals 2. Minimise delays in transfers as same infusions can be taken across by transport team 3. Minimising drug errors by using standardised formulations. 4. Improved nutrition to babies by protecting PN volume even when baby receives other infusions 5. Facilitation of standardised PN regimen across the Lancashire & South Cumbria network LSC Common Infusions for Neonatal Use Page 3

Adrenaline (Epinephrine) for intravenous infusion (Smart pump enabled) Drug Dosage & Route of Administration Route Dosage Frequency (times daily) IV Infusion Dose range: 100nanogram 1.5 microgram/kg/minute; adjust according to response Continuous Infusion Use of Adrenaline Available Concentration: Adrenaline 1 in 1000 (1mg/mL) solution For continuous intravenous infusion, administer through a central venous catheter or peripherally inserted central catheter using smart pump (if available) For babies of different weight bands on smart pump, use the following table to make up appropriate strength infusions: Less than 1 kg 1 2.499 kg 2.5 3.999 kg 4 6 kg Standard strength Enabled Enabled Enabled Enabled Double strength Enabled Enabled Enabled Enabled Formula to prepare a STANDARD STRENGTH intravenous infusion of Adrenaline 3 x babies weight (kg) = number of milligrams adrenaline to be diluted to a final volume of 50mL 100nanograms/kg/minute at an infusion rate of 0.1mL/hour 500nanograms/kg/minute at an infusion rate of 0.5mL/hour 1.5micrograms/kg/minute at an infusion rate of 1.5mL/hour Formula to prepare a DOUBLE STRENGTH intravenous infusion of Adrenaline 6 x babies weight (kg) = number of milligrams adrenaline to be diluted to a final volume of 50mL 200nanograms/kg/minute at an infusion rate of 0.1mL/hour 500nanograms/kg/minute at an infusion rate of 0.25mL/hour 1.5micrograms/kg/minute at an infusion rate of 0.75mL/hour Prescribe as X mg Adrenaline in Y ml diluent and add the rate of infusion to the infusion chart. NB: The final volume for Adrenaline and diluent must be 50mL. Storage / Stability Protect from light; discard discoloured solutions Once opened, discard any remainder Infusion stable for 24 hours at room temperature LSC Common Infusions for Neonatal Use Page 4

Other Information Compatible with the following infusion fluids: Incompatible with solutions of ph >7, Adrenaline is inactivated by sodium bicarbonate. References Paediatric Formulary Committee (2015). BNF for Children (2015-2016). London: BMJ Group, Pharmaceutical Press, and RCPCH Publications. Hey, E (2011). Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life. Chichester: Wiley-Blackwell. Aindow, A. Hill, H (2013). Paediatric Injectable Therapy Guidelines. Pharmacy Department Alder Hey Children s NHS Foundation Trust. Royal College of Paediatrics and Child Health. Neonatal and Paediatric Pharmacists Group (2003). Medicines for Children, 2 nd edition. London: RCPCH Publications Limited. LSC Common Infusions for Neonatal Use Page 5

Drug Dosage & Route of Administration Dobutamine for intravenous infusion (Smart pump enabled) Route Dosage Frequency (times daily) IV Infusion Initially 5microgram/kg/minute then adjust according to response. Dose range: 1-20microgram/kg/minute Continuous Infusion Use of Dobutamine Available Concentration: 250mg in 20mL ampoules For continuous intravenous infusion using smart pump (if available). See below with regards to route of administration. For babies of different weight bands on smart pump, use the following table to make up appropriate strength infusions: Less than 1 kg 1-2.499 kg 2.5 3.999 kg 4 6 kg Standard strength Not enabled Enabled Enabled Enabled Double strength Enabled Enabled Enabled Not enabled Quadruple strength Enabled Not enabled Not enabled Not enabled Infuse STANDARD STRENGTH via a peripheral or central line. Formula to prepare a STANDARD STRENGTH Continuous Intravenous Infusion of Dobutamine 30 x babies weight (kg) = number of milligrams Dobutamine to be diluted to a final volume of 50mL 5 micrograms/kg/minute at an infusion rate of 0.5 ml/hour 10 micrograms/kg/minute at an infusion rate of 1 ml/hour 20 micrograms/kg/minute at an infusion rate of 2 ml/hour Infuse DOUBLE & QUADRUPLE STRENGTH via a central line. Formula to prepare a DOUBLE STRENGTH Continuous Intravenous Infusion of Dobutamine 60 x babies weight (kg) = number of milligrams Dobutamine to be diluted to a final volume of 50mL 5 micrograms/kg/minute at an infusion rate of 0.25mL/hour 10 micrograms/kg/minute at an infusion rate of 0.5mL/hour 20 micrograms/kg/minute at an infusion rate of 1mL/hour Formula to prepare a QUADRUPLE STRENGTH Continuous Intravenous Infusion of Dobutamine 120 x babies weight (kg) = number of milligrams Dobutamine to be diluted to a final volume of 50mL LSC Common Infusions for Neonatal Use Page 6

4 micrograms/kg/minute at an infusion rate of 0.1mL/hour 10 micrograms/kg/minute at an infusion rate of 0.25mL/hour 20 micrograms/kg/minute at an infusion rate of 0.5mL/hour Prescribe as X mg Dobutamine in Y ml diluent and add the rate of infusion to the infusion chart. NB: The final volume for Dobutamine and diluent must be 50mL Storage / Stability Stable for 24 hours at room temperature Once opened discard any remainder Usual Maximum Concentration is 5mg/mL, i.e. 250mg in 50mL. However, concentrations of up to 10mg/mL have been used. Compatible with the following infusion fluids: Incompatible with sodium bicarbonate and other alkaline solutions. Solution may exhibit pink discolouration without loss of potency for up to 24 hours at room temperature. References Paediatric Formulary Committee (2015). BNF for Children (2015-2016). London: BMJ Group, Pharmaceutical Press, and RCPCH Publications. Hey, E (2011). Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life. Chichester: Wiley-Blackwell. Aindow, A. Hill, H (2013). Paediatric Injectable Therapy Guidelines. Pharmacy Department Alder Hey Children s NHS Foundation Trust. University College London Hospitals (2010). UCL Hospitals Injectable Medicines Administration Guide. 3rd edition. Oxford: Wiley-Blackwell. LSC Common Infusions for Neonatal Use Page 7

Drug Dosage & Route of Administration Dopamine for intravenous infusion (Smart pump enabled) Route Dosage Frequency (times daily) IV Infusion Initially 5microgram/kg/minute then adjust according to response. Dose range;1-20microgram/kg/minute Continuous Infusion Use of Dopamine Available Concentration: 200mg in 5mL ampoules For continuous intravenous infusion using smart pump (if available). See below with regards to route of administration. For babies of different weight bands on smart pump, use the following table to make up appropriate strength infusions: Less than 1 kg 1-2.499 kg 2.5 3.999 kg 4 6 kg Standard strength Not enabled Enabled Enabled Enabled Double strength Enabled Enabled Enabled Not enabled Quadruple strength Enabled Not enabled Not enabled Not enabled Infuse STANDARD STRENGTH via a peripheral or central line. Formula to prepare a STANDARD STRENGTH Continuous Intravenous Infusion of Dopamine 30 x babies weight (kg) = number of milligrams Dopamine to be diluted to a final volume of 50mL 5 micrograms/kg/minute at an infusion rate of 0.5mL/hour 10 micrograms/kg/minute at an infusion rate of 1 ml/hour 20 micrograms/kg/minute at an infusion rate of 2 ml/hour Infuse DOUBLE & QUADRUPLE STRENGTH via a central line. Formula to prepare a DOUBLE STRENGTH Continuous Intravenous Infusion of Dopamine 60 x babies weight (kg) = number of milligrams Dopamine to be diluted to a final volume of 50mL 5 micrograms/kg/minute at an infusion rate of 0.25mL/hour 10 micrograms/kg/minute at an infusion rate of 0.5mL/hour 20 micrograms/kg/minute at an infusion rate of 1mL/hour LSC Common Infusions for Neonatal Use Page 8

Formula to prepare a QUADRUPLE STRENGTH Continuous Intravenous Infusion of Dopamine 120 x babies weight (kg) = number of milligrams Dopamine to be diluted to a final volume of 50mL 4 micrograms/kg/minute at an infusion rate of 0.1mL/hour 10 micrograms/kg/minute at an infusion rate of 0.25mL/hour 20 micrograms/kg/minute at an infusion rate of 0.5mL/hour Prescribe as X mg Dopamine in Y ml diluent and add the rate of infusion to the infusion chart. NB: The final volume for Dopamine and diluent must be 50mL Storage / Stability Stable for 24 hours at room temperature Once opened discard any remainder Usual maximum concentration of final solution =3.2mg/mL i.e. 160mg in 50mL. However, concentrations of up to 5.1mg/mL have been used. Compatible with the following infusion fluids: Incompatible with sodium bicarbonate and other alkaline solutions Caution: Do not use yellow/brown discoloured solutions. Extravasation may cause local ischaemia and tissue necrosis. References Paediatric Formulary Committee (2015). BNF for Children (2015-2016). London: BMJ Group, Pharmaceutical Press, and RCPCH Publications. Hey, E (2011). Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life. Chichester: Wiley-Blackwell. Aindow, A. Hill, H (2013). Paediatric Injectable Therapy Guidelines. Pharmacy Department Alder Hey Children s NHS Foundation Trust. Summary of Product Characteristics. Dopamine 40 mg/ml Sterile Concentrate. http://www.medicines.org.uk/emc/medicine/630 (Accessed 22/04/2015) University College London Hospitals (2010). UCL Hospitals Injectable Medicines Administration Guide. 3rd edition. Oxford: Wiley-Blackwell. LSC Common Infusions for Neonatal Use Page 9

Insulin for intravenous infusion for Hyperglycaemia (Smart pump enabled) Drug Dosage & Route of Administration Route Dosage Frequency (times daily) IV Infusion Dose range:0.01-0.2units/kg/hour; adjust infusion rate according to response Continuous Infusion Use of Insulin Available Concentration: Soluble Insulin 100 international units/ml in 10mL multi-dose vials (Actrapid ) For continuous intravenous infusion using smart pump (if available). For babies of different weight bands on smart pump, use the following table to make up appropriate strength infusions: Less than 1 kg 1-2.499 kg 2.5 3.999 kg 4 6 kg Standard strength Not enabled Enabled Enabled Enabled Double strength Enabled Enabled Enabled Not enabled Quadruple strength Enabled Not enabled Not enabled Not enabled Formula to prepare a STANDARD STRENGTH Continuous Intravenous Infusion of Insulin 5 X babies weight (kg) = number of units Insulin to be diluted to a final volume of 50mL 0.01unit/kg/hour at an infusion rate of 0.1mL/hour 0.05unit/kg/hour at an infusion rate of 0.5mL/hour 0.15unit/kg/hour at an infusion rate of 1.5mL/hour Formula to prepare a DOUBLE STRENGTH Continuous Intravenous Infusion of Insulin 10 X babies weight (kg) = number of units Insulin to be diluted to a final volume of 50mL 0.02unit/kg/hour at an infusion rate of 0.1mL/hour 0.05unit/kg/hour at an infusion rate of 0.25mL/hour 0.15unit/kg/hour at an infusion rate of 0.75mL/hour Formula to prepare a QUADRUPLE STRENGTH Continuous Intravenous Infusion of Insulin 20 X babies weight (kg) = number of units Insulin to be diluted to a final volume of 50mL 0.04unit/kg/hour at an infusion rate of 0.1mL/hour 0.1unit/kg/hour at an infusion rate of 0.25mL/hour 0.2unit/kg/hour at an infusion rate of 0.5mL/hour Reconstitution of Vial: As per local policy LSC Common Infusions for Neonatal Use Page 10

Prescribe as X unit s insulin in Y ml diluent and add the rate of infusion to the infusion chart. NB: The final volume for insulin and diluent must be 50mL. Storage / Stability Ideally should be stored in a lockable fridge before opening. When opened, it should be stored in a lockable cupboard The vials should be discarded 6 weeks after first opening Do not use if the fluid appears heavy or coloured Compatible with the following infusion fluids: (may reduce potassium levels) References Paediatric Formulary Committee (2015). BNF for Children (2015-2016). London: BMJ Group, Pharmaceutical Press, and RCPCH Publications. Hey, E (2011). Neonatal Formulary: Drug Use in Pregnacy and the First Year of Life. Chichester: Wiley-Blackwell. Aindow, A. Hill, H (2013). Paediatric Injectable Therapy Guidelines. Pharmacy Department Alder Hey Children s NHS Foundation Trust. Summary of Product Characteristics: Actrapid 100 international units/ml, Solution for Injection in a vial. http://www.medicines.org.uk/emc/medicine/3513/spc/actrapid+100+iu+ml%2c+solution+fo r+injection+in+a+vial/ Accessed 07.12.2015 University College London Hospitals (2010). UCL Hospitals Injectable Medicines Administration Guide. 3rd edition. Oxford: Wiley-Blackwell. LSC Common Infusions for Neonatal Use Page 11

Morphine Sulfate for intravenous infusion (Smart pump enabled) Drug Dosage & Route of Administration Route Dosage Frequency IV Infusion Initially 20microgram/kg/hour then adjust according to response, Dose range;10-40microgram/kg/hour Continuous Infusion Use of Morphine Sulfate Available Concentrations: 1mg/mL ampoules 10mg/mL ampoules In order to prevent TEN FOLD dosing errors please be aware that Neonatal Units may stock either or both concentrations of Morphine Sulfate. Please check local policy. For continuous intravenous infusion using smart pump (if available). For babies of different weight bands on smart pump, use the following table to make up appropriate strength infusions: Less than 1 kg 1-2.499 kg 2.5 3.999 kg 4 6 kg Standard strength Enabled Enabled Enabled Enabled Double strength Enabled Enabled Enabled Enabled Formula to prepare a STANDARD STRENGTH Continuous infusion of Morphine Sulfate 2 X babies weight (kg) =number of milligrams Morphine Sulfate to be diluted to a final volume of 20mL 10micrograms/kg/hour at an infusion rate of 0.1 ml/hour 20micrograms/kg/hour at an infusion rate of 0.2 ml/hour Formula to prepare a DOUBLE STRENGTH Continuous Intravenous Infusion of Morphine Sulfate 4 X babies weight (kg) =number of milligrams Morphine Sulfate to be diluted to a final volume of 20mL 20 micrograms/kg/hour at an infusion rate of 0.1 ml/hour Prescribe as X mg Morphine Sulfate in Y ml diluent and add the rate of infusion to the infusion chart. NB: The final volume for Morphine Sulfate injection and diluent must be 20mL. Storage / Stability Controlled Drug: store ampoules in a Controlled Drugs cupboard. Infusion stable for 24 hours at room temperature Supplies must to be ordered in the CD requisition book. Compatible with the following infusion fluids: LSC Common Infusions for Neonatal Use Page 12

Incompatible with sodium bicarbonate and other alkaline solutions Morphine salts are sensitive to changes in ph and morphine sulfate is liable to be precipitated out of solution in an alkaline environment. References Aindow, A. Hill, H (2013). Paediatric Injectable Therapy Guidelines. Pharmacy Department Alder Hey Children s NHS Foundation Trust. Hey, E (2011). Neonatal Formulary: Drug Use in Pregnacy and the First Year of Life. Chichester: Wiley-Blackwell. Paediatric Formulary Committee (2015) BNF for Children (2015-2016). London: BMJ Group, Pharmaceutical Press, and RCPCH Publications. Summary of Product Characteristics. Morphine Sulfate 10mg/mL Injection BP. http://www.medicines.org.uk/emc/medicine/13143 (Accessed 21/04/2015) University College London Hospitals (2010). UCL Hospitals Injectable Medicines Administration Guide. 3rd edition. Oxford: Wiley-Blackwell. LSC Common Infusions for Neonatal Use Page 13

Appendix 1 Example of PN Fluid administration Below is example of volume of fluids given to babies with extremely low birth weight (based on birth weight <1.25kg). These are the babies whose TPN volume does get compromised currently when they are started on various infusions, especially inotropes or paralytic agents as shown below. Weight (Kg) Total fluids ml/kg/ day Total fluid (ml/hour) TPN volume protection ml/kg/day Total Fluid Volume remaining for all infusions after TPN volume protected (ml/hour) Heparin Sodium in Sodium Chloride 0.45% Infusion (ml/hour) Morphine Sulfate Infusion 10micrograms/kg/ hour = 0.1mL/hour Supplementary Infusion (ml/hour) 0.5 90 1.88 60 0.63 0.3 0.1 0.23 0.5 120 2.5 90 0.63 0.3 0.1 0.23 0.5 150 3.13 120 0.63 0.3 0.1 0.23 0.75 90 2.81 60 0.94 0.3 0.1 0.54 0.75 120 3.75 90 0.94 0.3 0.1 0.54 0.75 150 4.69 120 0.94 0.3 0.1 0.54 1 90 3.75 60 1.25 0.5 0.1 0.65 1 120 5 90 1.25 0.5 0.1 0.65 1 150 6.25 120 1.25 0.5 0.1 0.65 1.25 90 4.69 60 1.56 0.5 0.1 0.96 1.25 120 6.25 90 1.56 0.5 0.1 0.96 1.25 150 7.81 120 1.56 0.5 0.1 0.96 1.5 90 4.69 60 1.88 0.5 0.1 1.28 1.5 120 6.25 90 1.88 0.5 0.1 1.28 1.5 150 7.81 120 1.88 0.5 0.1 1.28 LSC Common Infusions for Neonatal Use Page 14

MORPHINE INSULIN DOPAMINE DOBUTAMINE ADRENALINE Appendix 2 - Summary of infusion monographs Please see monographs for full details DRUG Final Syringe Volume 50mL Amount of drug Diluent 50mL Amount of drug Diluent 50mL Amount of drug Diluent 50mL Amount of drug Diluent 20mL Amount of drug Diluent STANDARD STRENGH DOUBLE STRENGTH QUADRAPLE STRENGTH Comments 100nanograms/kg/minute =0.1mL/hour 200nanograms/kg/minute =0.1mL/hour N/A 3mg/kg 6mg/kg N/A 10micrograms/kg/minute =1mL/hour 10micrograms/kg/minute =0.5mL/hour N/A 10micrograms/kg/minute =0.25mL/hour 30mg/kg 60mg/kg 120mg/kg 10micrograms/kg/minute =1mL/hour 10micrograms/kg/minute =0.5mL/hour 10micrograms/kg/minute =0.25mL/hour 30mg/kg 60mg/kg 120mg/kg 0.1units/kg/hour =1mL/hour 0.1units/kg/hour =0.5mL/hour 0.1units/kg/hour =0.25mL/hour 5units/kg 10units/kg 20units/kg 10micrograms/kg/hour =0.1mL/hour 20micrograms/kg/hours = 0.1mL/hour N/A 2mg/kg 4mg/kg N/A N/A Standard and Double strength valid across all weight ranges No Quadruple strength Standard strength only valid for 1kg Double strength- only valid for <4 kg Quadruple strength - only valid for < 1kg Standard strength only valid for 1kg Double strength- only valid for <4 kg Quadruple strength - only valid for < 1kg Standard strength only valid for 1kg Double strength- only valid for <4 kg Quadruple strength - only valid for < 1kg Standard and Double strength valid across all weight ranges No Quadruple strength LSC Common Infusions for Neonatal Use Page 15